Advertisement

Current Psychiatry Reports

, Volume 9, Issue 3, pp 236–241 | Cite as

Psychogenic polydipsia review: Etiology, differential, and treatment

  • Brian Dundas
  • Melissa Harris
  • Meera Narasimhan
Article

Abstract

Psychogenic polydipsia (PPD), a clinical disorder characterized by polyuria and polydipsia, is a common occurrence in inpatients with psychiatric disorders. The underlying pathophysiology of this syndrome is unclear, and multiple factors have been implicated, including a hypothalamic defect and adverse medication effects. Hyponatremia in PPD can progress to water intoxication and is characterized by symptoms of confusion, lethargy, and psychosis, and seizures or death. Evaluation of psychiatric patients with polydipsia warrants a comprehensive evaluation for other medical causes of polydipsia, polyuria, hyponatremia, and the syndrome of inappropriate secretion of antidiuretic hormone. The management strategy in psychiatric patients should include fluid restriction and behavioral and pharmacologic modalities.

Keywords

Diabetes Insipidus Ecstasy Urine Osmolality Nephrogenic Diabetes Insipidus Conivaptan 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Kruse D, Pantelis C, Rudd R, et al.: Treatment of psychogenic polydipsia: comparison of risperidone and olanzapine, and the effects of an adjunctive angiotensin-II receptor blocking drug (irbesartan). Aust N Z J Psychiatry 2001, 35:65–68.PubMedCrossRefGoogle Scholar
  2. 2.
    Verghese C, de Leon J, Josiassen RC: Problems and progress in the diagnosis and treatment of polydipsia and hyponatremia. Schizophr Bull 1996, 22:455–464.PubMedGoogle Scholar
  3. 3.
    de Leon J: Polydipsia—a study in a long-term psychiatric unit. Eur Arch Psychiatry Clin Neurosci 2003, 253:37–39.PubMedCrossRefGoogle Scholar
  4. 4.
    Illowsky BP, Kirch DG: Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry 1988, 145:675–683.PubMedGoogle Scholar
  5. 5.
    Hariprasad MK, Eisinger RP, Nadler RM, et al.: Hyponatremia in psychogenic polydipsia. Arch Intern Med 1980, 140:1639–1642.PubMedCrossRefGoogle Scholar
  6. 6.
    Gillum DM, Linas SL: Water intoxication in a psychotic patient with normal water excretion. Am J Med 1984, 77:773–774.PubMedCrossRefGoogle Scholar
  7. 7.
    Jose CJ, Perez-Cruet J: Incidence and morbidity of self-induced water intoxication in state mental hospital patients. Am J Psychiatry 1979, 136:221–222.PubMedGoogle Scholar
  8. 8.
    Klonoff DC, Jurow AH: Acute water intoxication as a complication of urine drug testing in the workplace. JAMA 1991, 265:84–85.PubMedCrossRefGoogle Scholar
  9. 9.
    Fricchione G, Kelleher S, Ayyala M: Coexisting central diabetes insipidus and psychogenic polydipsia. J Clin Psychiatry 1987, 48:75–76.PubMedGoogle Scholar
  10. 10.
    Stuart CA, Neelon FA, Lebovitz HE: Disordered control of thirst in hypothalamic-pituitary sarcoidosis. N Engl J Med 1980, 303:1078–1082.PubMedCrossRefGoogle Scholar
  11. 11.
    Thompson CJ, Edwards CR, Baylis PH: Osmotic and nonosmotic regulation of thirst and vasopressin secretion in patients with compulsive water drinking. Clin Endocrinol (Oxf) 1991, 35:221–228.Google Scholar
  12. 12.
    Thompson CJ, Selby P, Baylis PH: Reproducibility of osmotic and nonosmotic tests of vasopressin secretion in men. Am J Physiol 1991, 260:R533–R539.PubMedGoogle Scholar
  13. 13.
    Rao KJ, Miller M, Moses A: Water intoxication and thioridazine (Mellaril). Ann Intern Med 1975, 82:61.PubMedGoogle Scholar
  14. 14.
    Fraser CL, Arieff AI: Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med 1997, 102:67–77.PubMedCrossRefGoogle Scholar
  15. 15.
    Douglas I: Hyponatremia: why it matters, how it presents, how we can manage it. Cleve Clin J Med 2006, 73(Suppl 3):S4–S12.PubMedCrossRefGoogle Scholar
  16. 16.
    Tomiyama J, Kametani H, Kumagai Y, et al.: Water intoxication and rhabdomyolysis. Jpn J Med 1990, 29:52–55.PubMedGoogle Scholar
  17. 17.
    Wicki J, Rutschmann OT, Burri H, et al.: Rhabdomyolysis after correction of hyponatremia due to psychogenic polydipsia possibly complicated by clozapine. Ann Pharmacother 1998, 32:892–895.PubMedCrossRefGoogle Scholar
  18. 18.
    Twardowschy CA, Bertolucci CB, Gracia Cde M, Brandao MA: Severe hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with fluoxetine: case report [in Portuguese]. Arq Neuropsiquiatr 2006, 64:142–145.PubMedGoogle Scholar
  19. 19.
    Sachdeo RC, Wasserstein A, Mesenbrink PJ, D’souza J: Effects of oxcarbazepine on sodium concentration and water handling. Ann Neurol 2002, 51:613–620.PubMedCrossRefGoogle Scholar
  20. 20.
    Flegel KM, Cole CH: Inappropriate antidiuresis during carbamazepine treatment. Ann Intern Med 1977, 87:722–723.PubMedGoogle Scholar
  21. 21.
    Spital A: Diuretic-induced hyponatremia. Am J Nephrol 1999, 19:447–452.PubMedCrossRefGoogle Scholar
  22. 22.
    Wilkins B: Cerebral oedema after MDMA (“ecstasy”) and unrestricted water intake. Hyponatremia must be treated with low water input. BMJ 1996, 313:689–690.PubMedGoogle Scholar
  23. 23.
    Holden R, Jackson MA: Near-fatal hyponatraemic coma due to vasopression over-secretion after “ecstasy” (3,4-MDMA) [letter]. Lancet 1996, 347:1052.PubMedCrossRefGoogle Scholar
  24. 24.
    Thaler SM, Teitelbaum I, Berl T: “Beer potomania” in non-beer drinkers: effect of low dietary solute intake. Am J Kidney Dis 1998, 31:1028–1031.PubMedGoogle Scholar
  25. 25.
    Rose BD, Post TW, Narins R: Hyperosmolal states—hyponatremia and hyperosmolal states—hyperglycemia. In Clinical Physiology of Acid-Base and Electrolyte Disorders, edn 5. New York: McGraw-Hill; 2001:748–757, 767–772.Google Scholar
  26. 26.
    Tierney LM, Jr, McPhee SJ, Papadakis MA: Fluid and electrolyte disorders and endocrinology. In Current Medical Diagnosis and Treatment, edn 42. New York: McGraw-Hill; 2003:840–845, 1076–1077.Google Scholar
  27. 27.
    Goldman MB, Robertson GL, Luchins DJ, Hedeker D: The influence of polydipsia on water excretion in hyponatremic, polydipsic, schizophrenic patients. J Clin Endocrinol Metab 1996, 81:1465–1470.PubMedCrossRefGoogle Scholar
  28. 28.
    Zerbe RL, Robertson GL: A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. N Engl J Med 1981, 305:1539–1546.PubMedCrossRefGoogle Scholar
  29. 29.
    Costanzo ES, Antes LM, Christensen AJ: Behavioral and medical treatment of chronic polydipsia in a patient with schizophrenia and diabetes insipidus. Psychosom Med 2004, 66:283–286.PubMedCrossRefGoogle Scholar
  30. 30.
    Moses AM, Clayton B: Impairment of osmotically stimulated AVP release in patients with primary polydipsia. Am J Physiol 1993, 265:R1247–R1252.PubMedGoogle Scholar
  31. 31.
    Neurology resident web page, medicine pocketbook kidney section. University of Western Ontario Clinical Neurosciences website. Available at: www.uwo.ca/cns/resident/pocketbook/medicine/kidney/hyponatremia.html. Accessed February 28, 2007.Google Scholar
  32. 32.
    Offenstadt G, Das V: Hyponatremia, hypernatremia: a physiological approach. Minerva Anestesiol 2006, 72:353–356.PubMedGoogle Scholar
  33. 33.
    Veiweg WV, Godleski LS, Graham P, et al.: Abnormal diurnal weight gain among long-term patients with schizophrenic disorders. Schizophr Res 1988, 1:67–71.CrossRefGoogle Scholar
  34. 34.
    Bowen L, Glynn SM, Marshall BD, Jr, et al.: Successful behavioral treatment of polydipsia in a schizophrenic patient. J Behav Ther Exp Psychiatry 1990, 21:53–61.PubMedCrossRefGoogle Scholar
  35. 35.
    Leadbetter RA, Shutty MS, Jr: Differential effects of neuroleptic and clozapine on polydipsia and intermittent hyponatremia. J Clin Psychiatry 1994, 55(Suppl B):110–113.PubMedGoogle Scholar
  36. 36.
    Lee HS, Kwon KY, Alphs LD, Meltzer HY: Effect of clozapine on psychogenic polydipsia in chronic schizophrenia [letter]. J Clin Psychopharmacol 1991, 11:222–223.PubMedCrossRefGoogle Scholar
  37. 37.
    Alexander RC, Karp BI, Thompson S, et al.: A double blind, placebo-controlled trial of demeclocycline treatment of polydipsia-hyponatremia in chronically psychotic patients. Biol Psychiatry 1991, 30:417–420.PubMedCrossRefGoogle Scholar
  38. 38.
    Greendyke RM, Bernhardt AJ, Tasbas HE, Lewandowski KS: Polydipsia in chronic psychiatric patients: therapeutic trials of clonidine and enalapril. Neuropsychopharmacology 1998, 18:272–281.PubMedCrossRefGoogle Scholar
  39. 39.
    Sebastian CS, Bernardin AS: Comparison of enalapril and captopril in the management of self-induced water intoxication. Biol Psychiatry 1990, 27:787–790.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group LLC 2007

Authors and Affiliations

  1. 1.Department of Neuropsychiatry and Behavioral SciencesUniversity of South Carolina School of MedicineColumbiaUSA

Personalised recommendations